Skip to main content

Health and medicine/Diseases and disorders

Within the next two years, people will be able to get their entire genome sequenced for less than $1000, a feat that could accelerate customized medical treatments, experts said at a recent AAAS colloquium on personalized medicine.

It’s an impressive technical breakthrough, but physicians, policymakers and others at the event are already worried about a 21st century blitz of lawsuits, ethical quandaries, and logistical issues stemming from inexpensive genome screening.